4//SEC Filing
Marchiando Keith 4
Accession 0001654954-24-007461
CIK 0001101026other
Filed
Jun 5, 8:00 PM ET
Accepted
Jun 6, 6:26 PM ET
Size
13.3 KB
Accession
0001654954-24-007461
Insider Transaction Report
Form 4
Marchiando Keith
Chief Financial Officer
Transactions
- Disposition to Issuer
Nonstatutory Stock Option to Purchase Common Stock
2024-06-05−48,000→ 0 totalExercise: $33.00Exp: 2031-10-20→ Common Stock (48,000 underlying) - Award
Nonstatutory Stock Option to Purchase Common Stock
2024-06-05+444,498→ 444,498 totalExercise: $7.96Exp: 2034-06-04→ Common Stock (444,498 underlying) - Disposition to Issuer
Nonstatutory Stock Option to Purchase Common Stock
2024-06-05−10,333→ 0 totalExercise: $23.64Exp: 2032-08-28→ Common Stock (10,333 underlying) - Disposition to Issuer
Nonstatutory Stock Option to Purchase Common Stock
2024-06-05−27,083→ 0 totalExercise: $67.20Exp: 2030-12-31→ Common Stock (27,083 underlying)
Footnotes (6)
- [F1]The share amount and exercise price have been adjusted from the amount reported on a previous Form 4 to reflect a 1 for 80 reverse stock split of the Issuer's stock in May 2021 and a 1 for 6 reverse stock split of the Issuer's stock in October 2023, as applicable.
- [F2]The canceled option was fully vested.
- [F3]The Issuer canceled options for an aggregate 85,416 shares of the Issuer's common stock granted to the Reporting Person on 1/1/2021, 10/21/2021, and 8/29/2022. In exchange for the canceled options, the Reporting Person received a replacement option, for 444,498 shares, having an exercise price of $7.96.
- [F4]The canceled option was issued pursuant to the 2021 Equity Incentive Plan on 10/21/2021 and vested as follows: 25% upon acceptance of the grant, and 25% on each of the next three calendar anniversaries of the grant.
- [F5]The canceled option was issued pursuant to the 2021 Equity Incentive Plan on 8/29/2022 and vested as follows: 25% upon acceptance of the grant, and 25% on each of the next three calendar anniversaries of the grant.
- [F6]The option was issued pursuant to the 2021 Equity Incentive Plan and vests as follows: 328,065 immediately upon grant acceptance, 13,551 on July 1, 2024, 13,442 on August 28, 2024, 62,447 on October 21, 2024, 13,551 on January 1, 2025, and 13,442 on August 28, 2025.
Documents
Issuer
Zivo Bioscience, Inc.
CIK 0001101026
Entity typeother
Related Parties
1- filerCIK 0001291432
Filing Metadata
- Form type
- 4
- Filed
- Jun 5, 8:00 PM ET
- Accepted
- Jun 6, 6:26 PM ET
- Size
- 13.3 KB